Evaluation of concentrated growth factor and blood clot as scaffolds in regenerative endodontic procedures: A retrospective study

Aust Endod J. 2023 Aug;49(2):332-343. doi: 10.1111/aej.12666. Epub 2022 Jul 25.

Abstract

The study aims to investigate and compare the success rate of concentrated growth factor (CGF) and blood clot (BC) as scaffolds in regenerative endodontic procedures (REPs). Immature permanent necrotic teeth treated by REPs with at least a 6-month follow-up were included. These teeth were divided into the CGF (53 teeth) and BC (68 teeth) groups. Treatment outcomes were assessed using a combined clinical and radiographic scoring system. The total success rate was 91.74% over a mean follow-up period of 23.15 months. There was no significant difference between the CGF group (86.79%) and BC group (95.59%). The success rate of traumatic teeth (84.31%) was significantly lower than that of teeth with developmental dental anomalies (98.39%) (p < 0.05). CGF may be a suitable alternative scaffold in REPs when adequate bleeding cannot be achieved. Moreover, compared to developmental dental anomalies, traumatic teeth treated by REPs may be more vulnerable to failure.

Keywords: paediatric dentistry; periapical periodontitis; permanent dentition; regenerative endodontics; scaffold.

MeSH terms

  • Dental Pulp Necrosis / therapy
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Regenerative Endodontics*
  • Retrospective Studies
  • Thrombosis*

Substances

  • Intercellular Signaling Peptides and Proteins